Anuradha Anand, MD
Physical Medicine & Rehabilitation · Seven Fields, PANPI 1366758989
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,709 of the $5,726 with a category attached, or 82.3%. It is spread thinly across 21 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,248 and has fallen 83.4% since, to $374 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 158 payments — averaging $36.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Pacira Pharmaceuticals Incorporated$1K
- Medtronic$863
- AbbVie$511
- Ipsen Biopharmaceuticals, Inc$439
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$408
- plus $1K from 15 others
What the payments were for
- Travel & lodging$97417%
- Food & beverage$4,70982%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 22 | $1,328 |
| Pacira Pharmaceuticals Incorporated | 8 | $1,052 |
| Medtronic(2 entities) | 11 | $863 |
| AbbVie(2 entities) | 28 | $511 |
| Ipsen Biopharmaceuticals, Inc | 10 | $439 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $408 |
| Collegium Pharmaceutical, Inc. | 15 | $277 |
| Biodelivery Sciences International, Inc. | 15 | $175 |
| Valinor Pharma, LLC | 9 | $163 |
| AstraZeneca | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $117 |
| Lundbeck LLC | 4 | $84 |
| Redhill Biopharma Inc. | 2 | $30 |
| Relievant Medsystems, Inc. | 1 | $30 |
| Tersera Therapeutics LLC | 1 | $21 |
| Virtus Pharmaceuticals LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Pfizer | 1 | $20 |
| Si-bone, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| International Rehabilitative Sciences, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IOVERA SYSTEM$866
- VANTA ADAPTIVESTIM$459
- Proclaim IPG$366
- OCTRODE$157
- INTELLIS ADAPTIVESTIM$147
- PROCLAIM$133
- TAGRISSO$125
- DYSPORT$124
- OPDIVO$117
How this compares
$5,726 in reported general payments places this provider in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
See all physical medicine & rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 88 | $185,447 |
| BelbucaBuprenorphine Hcl | 89 | $69,100 |
| Xtampza ErOxycodone Myristate | 101 | $55,357 |
| MovantikNaloxegol Oxalate | 97 | $42,182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 942 | $30,149 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 794 | $20,564 |
| Oxymorphone Hcl ErOxymorphone Hcl | 76 | $20,142 |
| Oxycodone Hcl | 804 | $15,234 |
| LinzessLinaclotide | 28 | $14,974 |
| BotoxOnabotulinumtoxina | 12 | $14,890 |
| OxycontinOxycodone Hcl | 27 | $14,638 |
| Buprenorphine | 72 | $10,831 |
| Ajovy SyringeFremanezumab-Vfrm | 14 | $10,469 |
| SymproicNaldemedine Tosylate | 21 | $8,912 |
| Morphine Sulfate ErMorphine Sulfate | 337 | $8,400 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $408 | $185,44788 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $277 | $124,457190 claims |
| Redhill Biopharma Inc.Movantik | $30 | $42,18297 claims |
| AbbVieLinzess, Botox | $511 | $29,86340 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
Other physical medicine & rehabilitation in Seven Fields
- Jeffery RoweKing Of Prussia$1.9M
- Michael SaulinoElkins Park$425K
- Huaguang QuChalfont$356K
- Alberto EsquenaziPhiladelphia$305K
- Mitchell PaulinPaoli$229K
- Kimberly HeckertPhiladelphia$119K
- David LichtenReading$117K
- Gay WilcherRidley Park$81K
- Jessica MulhernPaoli$79K
- Leonard KamenElkins Park$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.